Background <p>Myeloid-derived suppressor cells (MDSCs) play a pivotal role in shaping the immunosuppressive tumor microenvironment, thereby driving tumor progression and contributing to resistance to therapy. The surface molecules expressed on MDSCs serve not only as identification markers but also as critical regulators of their immunosuppressive functions. Identifying surface markers that are both widely expressed and functionally significant on MDSCs is…
CD55-expressing myeloid-derived suppressor cells (MDSCs) drive cancer immunoevasion
Journal for ImmunoTherapy of Cancer | | Jiang, X., Yan, N., Wu, H., Wang, W., Wang, X., Chen, J., Wu, A., An, J., Wang, C., Lin, J., Li, Y., Wen, Y., Zhuang, K., Xie, L., Li, P., Liu, F., Liu, Y.
Topics: skin-cancer, blood-cancer, new-technology
Read the full article at Journal for ImmunoTherapy of Cancer